ABAT and early-onset autosomal dominant Alzheimer disease: Moreover, decreased levels of GABA transaminase (GABA-T), a known catabolizer of GABA into succinic semialdehyde, are also profound in choreoathetosis, encephalopathy, hypersomnolence, Alzheimer's disease, and epilepsy.